Brief: Ascendis Pharma Announces R&D Day On June 26 To Review Endocrinology Rare Disease Pipeline And Introduce Oncology Programs
19/06/2019 13:35
June 19 (Reuters) - Ascendis Pharma A/S ASND.O :
* ASCENDIS PHARMA A/S ANNOUNCES RESEARCH AND DEVELOPMENT DAY
ON
JUNE 26 TO REVIEW ENDOCRINOLOGY RARE DISEASE PIPELINE AND
INTRODUCE ONCOLOGY PROGRAMS
* ASCENDIS PHARMA A/S - CONTINUED PROGRESS OF ALL THREE
GLOBAL
ENDOCRINOLOGY RARE DISEASE PROGRAMS
Source text for Eikon: ID:nGNX6G1k1D
Further company coverage: ASND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascendis Pharma A/S
See all newsAscendis Pharma tumbles on Novo Nordisk collab termination
BioMarin climbs on global patent settlement with Ascendis
Brief: Ascendis Announces Oral Presentation Of Week 104 Data From Its Pivotal Trial Of Transcon® CNP (Navepegritide) At Isds 2026
Brief: Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Ascendis Pharma A/S reports results for the quarter ended June 30 - Earnings Summary